These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 18340391

  • 1. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?
    Göçmen AY, Sahin E, Semiz E, Gümuşlü S.
    Can J Cardiol; 2008 Mar; 24(3):209-12. PubMed ID: 18340391
    [Abstract] [Full Text] [Related]

  • 2. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY, Gümüşlü S, Semiz E.
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [Abstract] [Full Text] [Related]

  • 3. Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region.
    Göçmen YA, Semiz E, Gümüşlü S.
    Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):185-6. PubMed ID: 15785307
    [Abstract] [Full Text] [Related]

  • 4. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
    Göçmen AY, Sahin E, Koçak H, Tuncer M, Gümüşlü S.
    Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
    [Abstract] [Full Text] [Related]

  • 5. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
    Singh S, Venketesh S, Verma JS, Verma M, Lellamma CO, Goel RC.
    Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
    [Abstract] [Full Text] [Related]

  • 6. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
    Serdar Z, Yeşilbursa D, Dirican M, Sarandöl E, Serdar A.
    Cell Biochem Funct; 2007 Jun; 25(6):655-64. PubMed ID: 17006879
    [Abstract] [Full Text] [Related]

  • 7. Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
    Mahrooz A, Shokri Y, Variji A, Zargari M, Alizadeh A, Mehtarian E.
    Nutr Metab Cardiovasc Dis; 2021 Apr 09; 31(4):1166-1176. PubMed ID: 33579580
    [Abstract] [Full Text] [Related]

  • 8. Relationship between high density lipoprotein antioxidant activity and carotid arterial intima-media thickness in patients with essential hypertension.
    Chen X, Wu Y, Liu L, Su Y, Peng Y, Jiang L, Liu X, Huang D.
    Clin Exp Hypertens; 2010 Jan 09; 32(1):13-20. PubMed ID: 20144068
    [Abstract] [Full Text] [Related]

  • 9. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Shen Y, Ding FH, Sun JT, Pu LJ, Zhang RY, Zhang Q, Chen QJ, Shen WF, Lu L.
    Cardiovasc Diabetol; 2015 May 13; 14():52. PubMed ID: 25964115
    [Abstract] [Full Text] [Related]

  • 10. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y, Toh R, Hasokawa M, Nakajima H, Honjo T, Otsui K, Mori K, Miyamoto-Sasaki M, Shinohara M, Nishimura K, Ishida T, Hirata K.
    Atherosclerosis; 2014 Jun 13; 234(2):288-94. PubMed ID: 24704632
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI, Dos Reis RP, Freitas AI, Pereira A, Sousa AC, Freitas S, Ornelas I, Freitas C, Brehm A, Araújo JJ.
    Rev Port Cardiol; 2010 Apr 13; 29(4):571-80. PubMed ID: 20734577
    [Abstract] [Full Text] [Related]

  • 13. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K, Naruko T, Inaba M, Inoue T, Nakagawa M, Sugioka K, Ohsawa M, Iwasa Y, Komatsu R, Itoh A, Haze K, Yoshiyama M, Becker AE, Ueda M.
    Atherosclerosis; 2013 Dec 13; 231(2):308-14. PubMed ID: 24267244
    [Abstract] [Full Text] [Related]

  • 14. Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease.
    Martinelli N, Micaglio R, Consoli L, Guarini P, Grison E, Pizzolo F, Friso S, Trabetti E, Pignatti PF, Corrocher R, Olivieri O, Girelli D.
    Exp Diabetes Res; 2012 Dec 13; 2012():231502. PubMed ID: 21960992
    [Abstract] [Full Text] [Related]

  • 15. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA, Mansur AP, Ribeiro CC, Ramires JA, Annichino-Bizzacchi JM.
    Int J Cardiol; 2004 Mar 13; 94(1):73-7. PubMed ID: 14996478
    [Abstract] [Full Text] [Related]

  • 16. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S.
    Clin Endocrinol (Oxf); 2004 Oct 13; 61(4):515-21. PubMed ID: 15473886
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The relationship between oxidative stress markers and visual evoked potentials in different hypertension models.
    Göçmen AY, Celikbilek A, Hacıoğlu G, Tanık N, Ağar A, Yargıcoğlu P, Gümüşlü S.
    Anadolu Kardiyol Derg; 2014 Sep 13; 14(6):498-504. PubMed ID: 25233495
    [Abstract] [Full Text] [Related]

  • 19. Association of serum antioxidant capacity with coronary artery disease in middle-aged men.
    Nojiri S, Daida H, Mokuno H, Iwama Y, Mae K, Ushio F, Ueki T.
    Jpn Heart J; 2001 Nov 13; 42(6):677-90. PubMed ID: 11933918
    [Abstract] [Full Text] [Related]

  • 20. Low serum paraoxonase1 activity levels predict coronary artery disease severity.
    Sun T, Hu J, Yin Z, Xu Z, Zhang L, Fan L, Zhuo Y, Wang C.
    Oncotarget; 2017 Mar 21; 8(12):19443-19454. PubMed ID: 28038449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.